fda removes semaglutide from drug shortage list february 21 2025 The Ozempic Is Over Semaglutide shortage ends as FDA

Certain immunosuppressants used after organ transplantation can have half-lives of weeks

Forty-plus years of foundational literature

The confusion likely stems from two sources: unrelated concerns about high-dose intravenous glutathione injection practices used in some cosmetic clinics (a different delivery method with a different risk profile), and complex ongoing research into glutathione's role within existing cancer cells which is a completely separate scientific question from whether a healthy person taking an oral supplement faces increased cancer risk

When FDA-approved drugs are available, outsourcing facilities cannot lawfully compound using bulk drug substances unless there is a clear clinical need

doi: 10.1177/87551225221092681